Sources

6 Total Sources

Life Biosciences Doses First Patient in 18-Adult ER-100 Vision Loss Trial

Life Biosciences Doses First Human with ER-100 for Age-Related Sight Loss

Business Insider6h ago

Life Biosciences Injects First Human with Cellular Reprogramming Drug to Reverse Aging

lifespan.io6h ago

First Human Cellular Reprogramming Trial Cleared by the FDA

Harvard Medical School6h ago

Loss of Epigenetic Information Can Drive Aging, Restoration Can Reverse It | Harvard Medical School

In a proof-of-concept experiment, researchers at Michigan Medicine and Michigan Engineering designed several human cell types that were genetically modified with protein nanoparticles. With the nanoparticles, the research team aims to develop

BioSpace: Biotech, Pharmaceutical and Clinical Research News